Top View
- The Expression of CD5 Outside Germinal Centers Is Associated
- 978.Full.Pdf
- Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells
- CD5 T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
- Re-Evaluation of CD37 As Target for Radioimmunotherapy of Non-Hodgkin Lymphoma Jostein Dahle1, Ada Repetto1, Camilla Mollatt2, Katrine B
- Evaluating Antigen Targeting and Anti-Tumor Activity of a New Anti-CD37 Radioimmunoconjugate Against Non-Hodgkin’S Lymphoma
- CD20 Mab-Mediated Complement Dependent Cytotoxicity of Tumor Cells Is Enhanced by Blocking the Action of Factor I
- CD20-Targeted Therapy: a Breakthrough in the Treatment of Non-Hodgkin’S Lymphoma
- Enhancing the Efficacy of Anti-CD20 Monoclonal Antibody Therapy Through Manipulation of the Tumour Microenvironment
- Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies Karl R
- CD38, CD81 and BAFFR Combined Expression by Transitional B Cells Distinguishes Active from Inactive Systemic Lupus Erythematosus
- Genetic and Epigenetic Modulation of CD20 Expression in B-Cell Malignancies: Molecular Mechanisms and Significance to Rituximab Resistance
- Metastasis Suppressor Protein in Human Cancer Cell Lines
- CD20 and CD37 Antibodies Synergize to Activate Complement by Fc-Mediated Ferrata Storti Foundation Clustering
- Differential Adhesion Pattern of B Cell Chronic Lymphocytic Leukemia Cells
- Identification of a Candidate Gene Set Signature for the Risk Of
- CD20 As a Gatekeeper of the Resting State of Human B Cells Downloaded by Guest on September 28, 2021 INAUGURAL ARTICLE IMMUNOLOGY and INFLAMMATION
- The Role of Tetraspanin CD63 in Antigen Presentation to CD4+ T Cells
- Therapy-Related Changes of CD20 and CD45RO Lymphocyte
- Anti-Human CD20-171Yb
- Features of Human CD3+CD20+ T Cells
- Expression of B-Cell Surface Antigens in Subpopulations of Exosomes Released from B-Cell Lymphoma Cells
- CD37 in B Cell Derived Tumors—More Than Just a Docking Point for Monoclonal Antibodies
- Fc-Engineered Antibodies with Enhanced Fc-Effector Function For
- The CD151-Midkine Pathway Regulates the Immune Microenvironment in Inflammatory Breast Cancer
- CD5-Positive B Cells – Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Versus Mantle Cell Lymphoma
- CD40 Revealed As a B the Power Of
- CD20 and CD37 Antibodies Synergize to Activate Complement by Fc-Mediated Clustering
- Impact of Aberrant Antigens in the Outcome of Patients with Acute Leukemia at a Referral Institution
- The Context-Dependent Impact of Integrin-Associated CD151
- Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab in Vitro and in Xenograft Models
- Complement-Dependent Activity of CD20-Specific Igg Correlates With
- Antigen-Specific Targeting of Tissue-Resident Gamma Delta T
- Immunotherapy in Mice Memory B Cell Depletion During CD20 Serological Memory Despite Mature and Maintenance of Long-Lived Plasma
- FLOW CYTOMETRY PRINCIPLES and PRACTICE Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018 Aims and Objectives
- Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
- Diversity of Extracellular Vesicles Addressed by Immunoaffinity Beads
- Antibodies Mouse Monoclonal Igg2b Antibody Against Human, Rhesus, Cynomolgus CD20, FITC-Conjugated
- CD20 Positive T Cell Lymphoma: Is It a Real Entity? T Sun, a Akalin, M Rodacker, T Braun
- The CD151-Midkine Pathway Regulates the Immune Microenvironment in Inflammatory Breast Cancer
- Tetraspanin KAI1/CD82 Inhibits Cell Migration-Related Cellular Events Via Reorganizing Actin Network" (2007)
- CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
- Acute Leukemias of Ambiguous Origin
- Preclinical Characterization of AMG 330, a CD3/CD33- Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia
- MARKERS for IMMUNE CELLS 2 Markers for Immune Cells
- CD40 Signaling Pathway
- Antibodies Mouse Monoclonal Igg2b Antibody Against Human, Rhesus, Cynomolgus CD20, Unconjugated
- Guide to Human CD Antigens
- CD53, CD81, and CD82) at the Surface of a B Cell Line JY’
- Margin-Infiltrating CD20 B Cells Display an Atypical Memory
- CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin
- The Role of Tetraspanins in Neutrophil Survival and Phagocytosis
- Sirpα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells
- Rituximab Mode of Action CD20-Induced Apoptosis Classical
- A High Recovery and High Purity Data Analysis Strategy for Rare Abnormal CD5+ ROR-1+ B Cells Using the Duraclone RE CLB Tube